UCL Institute of Neurology
- IoN HOME
- About the Institute
- Study Here
- Research Departments
- Department of Brain Repair & Rehabilitation
- Department of Clinical and Experimental Epilepsy
- Department of Clinical Neuroscience
- Department of Molecular Neuroscience
- Department of Neurodegenerative Disease
- Department of Neuroinflammation
- Department Home
- Vacancies
- News
- Sources of support
- Publications
- Research themes
- Sobell Department of Motor Neuroscience and Movement Disorders
- Wellcome Department of Imaging Neuroscience
- Services & Library
- Vacancies and PhD Projects
- Contact Us
- National Hospital for Neurology and Neurosurgery
- Support Us
- IoN Intranet

- Department Home
- Vacancies
- News
- Sources of support
- Publications
-
Research themes
- Cell Signalling Laboratory
- Diagnosis, prognosis and therapeutic monitoring in MS
- Experimental neuroinflammation
- Magnetic resonance physics
- Mechanisms of disability and recovery in MS
- MRI & pathology in MS
- MS Clinical Trial Unit
- Neuroimmunology Unit
- Neuropsychiatry Group: Brain abnormalities in psychosis
- NeuroResource Tissue Bank
- NMR Research Unit
Publications
10 publications that illustrate the work of the Department
|
Bagary M. S., Symms M. R., Barker G. J., Mutsatsa S. H., Joyce E. M., Ron M. A. Gray and white matter brain abnormalities in first episode schizophrenia inferred from magnetization transfer imaging. |
|
Bruno S. D., Barker G. J., Cercignani M., Symms M., Ron M. A. A study of bipolar disorder using magnetization transfer imaging and voxel-based morphometry. |
|
Craner M. J., Newcombe J., Black J. A., Hartle C.,
Cuzner M. L., Waxman S. G. Molecular changes in neurons in multiple sclerosis: Altered axonal expression of Na(v)1.2 and Na(v)1.6 sodium channels and Na+/Ca2+ exchanger. |
|
Dale R. C., Church A. J., Surtees R. A., Lees A. J., Adcock J. E., Harding B., Neville B. G., Giovannoni G. Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity. |
|
Fernando K. T., McLean M. A., Chard D. T., MacManus D. G., Dalton C. M., Miszkiel K. A., Gordon R. M., Plant G. T., Thompson A. J., Miller D. H. Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis. |
|
Pryce G., Ahmed Z., Hankey D. J. R., Jackson S. J., Croxford J. L., Pocock J. M., Ledent C., Petzold A., Thompson A. J., Giovannoni G., Cuzner M. L., Baker D. Cannabinoids inhibit neurodegeneration in models of multiple sclerosis. |
|
Rejdak K., Eikelenboom M. J., Petzold A., Thompson E. J., Stelmasiak Z., Lazeron R. H. C., Barkhof F., Polman C. H., Uitdehaag B. M. J., Giovannoni G. CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis. |
|
Schmierer K., Scaravilli F., Altmann D. R., Barker
G. J., Miller D. H. Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain. |
|
Taylor D. L., Diemel L. T., Pocock J. M. Activation of microglial group III metabotropic glutamate receptors protects neurons against microglial neurotoxicity. |
|
Tozer D., Ramani A., Barker G. J., Davies G. R., Miller D. H., Tofts P. S. Quantitative magnetization transfer mapping of bound protons in multiple sclerosis. |

